Triaxis Polio 0.5 ml (difterie-anatoxine + tetanus-anatoxine + Bordetella pertussis antigenen + poliomyelitisvirus types I, II, III geïnactiveerd suspensie voor injectie (i.m.) (volw. en kind)) · CNK 4237939

Product information

Triaxis Polio 0.5 ml
0.5 ml + 1 x Injection needle
difterie-anatoxine + tetanus-anatoxine + Bordetella pertussis antigenen + poliomyelitisvirus types I, II, III geïnactiveerd suspensie voor injectie (i.m.) (volw. en kind)
4237939
0 / 10
Locked

Product properties

x
J07CA02
Sanofi Winthrop Industrie
Suspension for injection, Suspension for injection in pre-filled syringe
BE241096
03664798033403, 03664798054330
M1
Public
241096-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Other reason) and no stock is available from wholesalers. Switching to an alternative is necessary.

Recommended alternative

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Other reason

Alternative available

Composition

10 ingredients

Substance Type Strength CAS
Active ingredient
Active ingredient
40 [D'ag'U]
Active ingredient
5 ug/{dose}
Active ingredient
Active ingredient
5 ug/{dose}
Active ingredient
2.5 ug/{dose}
Active ingredient
32 [D'ag'U]
Active ingredient
3 ug/{dose}
Active ingredient
8 [D'ag'U]
Excipient
0.01 %

Additional information

View on BCPI

Availability statistics

Commercialization stopped
378 days
3
0
01/07/2026